IQ Advertising Consultants

Current News

Attorneys Appointed to Leadership Positions in Uber Sexual Assault MDLDec, 07 2023
Three woman have been selected to serve as co-lead counsel for all plaintiffs pursuing an Uber sexual assault lawsuits throughout the federal court system.test
Roundup Lawsuit Jury Awards Continue to Pile Up, With 5th Straight Plaintiff’s VerdictDec, 07 2023
A Philadelphia jury awarded $3 million in punitive damages in a Roundup lawsuit verdict returned this week, in the latest of a series of trials scheduled over the next year.test
Lead in Recalled Apple Sauce Pouches Linked to 64 Illnesses Among Children: FDADec, 07 2023
Officials believe the lead poisoning may be caused by cinnamon in the WanaBana, Weis and Schnucks apple sauce pouches, and additional sample testing is being performed to confirm the source.test
PFAS Contamination Found in Drinking Water of 44 Million Americans: ReportDec, 07 2023
Environmentalists indicate that more stringent measures are needed to detect and prevent PFAS drinking water contamination, which poses serious health risks for communities throughout the U.S.test
More Cantaloupe Recalls Announced Amid Growing Number of Salmonella Poisoning CasesDec, 07 2023
CDC investigators expect more cantaloupe food poisoning illnesses to be reported, due to salmonella's latency period, which means it can take three to four weeks for symptoms to develop.test
Lawyers Push for Camp Lejeune Water Lawsuits To Be Decided By Juries, Not JudgesDec, 06 2023
Plaintiffs are opposing a motion filed by the U.S. government, which would prevent juries from deciding Camp Lejeune water lawsuits being pursued by military veterans, family members and others.test
J&J Close to Reaching Mesothelioma Settlements to Resolve Talcum Powder LawsuitsDec, 06 2023
Talcum powder settlements were reached last month to resolve two mesothelioma lawsuits, which were prepared to go to trial involving allegations that asbestos in baby powder caused cancer.test
Teens Who Use Social Media Are More Likely to Endanger Their Own Health: StudyDec, 06 2023
As families throughout U.S. pursue social media addiction lawsuit, the Surgeon General has recommended age-restrictions for teen social media use, due to concerns over mental health damage.test
Class Action Lawsuit over Recalled Eye Drops Filed Against EzriCare, EzriRxDec, 06 2023
Georgia woman indicates she suffered vision loss from Ezricare Artificial Tears eye drops purchased at Walmart in 2022, which were recalled months later due to bacterial contamination.test
Men Face Higher Risk of Injury from Pedestrian Car Accidents: StudyDec, 05 2023
Findings come amid growing concerns about the increasing rates of pedestrian car accident injuries and deaths worldwide, including in the U.S.test

Carefully Monitor Philips DreamStation 2 CPAP Machines for Signs of Overheating: FDA Safety CommunicationDec, 07 2023
Reports of smoke, sparks, fire, and burns stemming from use of the DreamStation2 CPAP machines prompt warning from the FDA.
Cardinal Health Issues Medical Device Recall for Nurse Assist Products Contained Within Kits/TraysDec, 07 2023
In direct response to the Nurse Assist, LLC voluntary product recall (which included products supplied to Cardinal Health used in Covidien and Cardinal Health™ brand kits and trays), Cardinal Health issued a medical device recall on December 5, 2023, for its Covidien and Cardinal Health™ brand urolo
2023 Medical Device RecallsDec, 05 2023
2023 Medical Device Recalls
Cordis US Corp Recalls INFINITI Angiographic Catheter due to Products Being Shipped Without Undergoing Sterilization ProceduresDec, 05 2023
The Cordis INFINITI Angiographic Catheter is being recalled due to some of the products being shipped to end users without undergoing sterilization procedures.
Voluntary Recall of SoClean Equipment Intended for Use with CPAP Devices and Accessories: FDA Safety CommunicationDec, 04 2023
A voluntary recall initiated by SoClean for use of SoClean2 and SoClean3 equipment to clean, sanitize or disinfect CPAP devices and accessories.
Becton Dickinson (BD)/Carefusion 303 Recalls Alaris Infusion Pumps Due to Compatibility Issues with Cardinal Health Monoject SyringesDec, 01 2023
BD/Carefusion 303 is recalling their Alaris Infusion Pumps to make a correction on compatibility issues with Cardinal Health Monoject syringes.
Eitan Medical Ltd Recalls Sapphire Infusion Pumps for Failure to Detect Air in the LineDec, 01 2023
Sapphire Infusion Pumps are being recalled because they may fail to detect air in the line. The failure could cause injury or death.
2023 Safety CommunicationsNov, 30 2023
Listing of Medical Device 2023 Safety Communications
Evaluating Plastic Syringes Made in China for Potential Device Failures: FDA Safety CommunicationNov, 30 2023
Consider using plastic syringes not manufactured in China, if possible.
Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump Due to Potential Impact of Downstream Occlusions on Infusion VolumeNov, 30 2023
Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump. The Correction is due to the potential for an incomplete infusion following one or more downstream occlusion alarms. Baxter notified impacted customers in October and i
Left Atrial Appendage Occlusion (LAAO) Devices Potentially Associated with Procedural Outcome Differences Between Women and Men – Letter to Health Care ProvidersNov, 29 2023
Recommendations for health care providers due to potential procedural outcome differences between women and men undergoing procedures with LAAO devices.
Meta Herbal Issues Voluntary Nationwide Recall of Magnum XXL 9800 Capsules Due to Presence of Undeclared SildenafilNov, 29 2023
E. Hampton NY- Meta Herbal is voluntarily recalling 500 blister packs of Magnum XXL 9800 2000 mg per capsule, to the consumer level. The products have been found to be tainted with Sildenafil. Sildenafil is an ingredient known as a Phosphodiesterase Inhibitor (PDE-5) found in FDA-approved products f
Antiseizure Medicines Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam): Drug Safety Communication - FDA Warns of Rare but Serious Drug ReactionNov, 28 2023
The FDA is warning that the antiseizure medicines can cause a rare but serious reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), that can be life-threatening if not diagnosed and treated quickly.
BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies: FDA Safety Communication - FDA Investigating Serious Risk of T-cell MalignancyNov, 28 2023
The FDA has received reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment with BCMA- or CD19-directed autologous CAR T cell immunotherapies.
Unomedical A/S Recalls VariSoft Infusion Sets Due to Damage to the Connector Piece Causing Unexpected DisconnectionsNov, 27 2023
Unomedical A/S is recalling their Varisoft infusion set due to the connector detaching more easily than expected, thereby interrupting the delivery of insulin.
Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL Due to CrystallizationNov, 27 2023
Novartis is conducting a voluntary nationwide recall at the consumer level of two lots of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to crystal formation observed in some bottles, which could potentially result in incorrect dosing. The issue was identifi
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of BenzeneNov, 24 2023
Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third- party lab found that samples fr
Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial ContaminationNov, 21 2023
Bayer is voluntarily recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles to the consumer/user level. The product is being recalled due to microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing.
Noah’s Wholesale, LLC Issues Voluntary Nationwide Recall of the Rock Due to Presence of Undeclared SildenafilNov, 21 2023
Miami Gardens, Florida, Noah’s Wholesale, LLC is voluntarily recalling one lot of the rock# 03032021,exp:12/2027,1200 mg/capsule, to the consumer level. FDA analysis has found the product to be tainted with Sildenafil. Sildenafil is an ingredient known as a Phosphodiesterase Inhibitor (PDE-5) found
2023 Letters to Health Care ProvidersNov, 20 2023
The FDA posts letters to health care providers about the safe use of medical devices.